Notably, the correlation between SCN1A variant location (coding vs. non-coding) and pathogenic effects, the modulating role of polygenic backgrounds in phenotypic diversity, and the active participation of neuroglial cells in epileptogenic network formation provide critical insights into DS clinical heterogeneity. The gene discussed is SCN1A; the disease is Dravet syndrome.